The Relative Strength (RS) Rating for Surgery Partners stock climbed into a new percentile Monday, with an increase from 78 to 82.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This unique rating identifies technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the trailing 52 weeks matches up against that of all other stocks.
History reveals that the market's biggest winners tend to have an 80 or higher RS Rating as they begin their biggest price moves.
Looking For Winning Stocks? Try This Simple Routine
Is Surgery Partners Stock A Buy?
Surgery Partners stock had a recent failed breakout, thus it's not near an ideal entry right now, see if it manages to form and break out of a proper consolidation. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
While the company's top line growth fell last quarter from 13% to 11%, EPS grew 156%, up from 0% in the previous report.
Surgery Partners stock earns the No. 2 rank among its peers in the Medical-Hospitals industry group. Surgery Partners and HCA Holdings are also among the group's highest-rated stocks.
